Achilles Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Achilles Therapeutics generated cash of -$48,449,000, which is more than the previous year. Cash used in financing activities reached the amount of $9,000 last year. Net change in cash is therefore -$41,799,000.
Cash Flow
| 2019 | -14.14M | -942K | 93.62M |
|---|---|---|---|
| 2020 | -25.25M | -11.84M | 113.70M |
| 2021 | -59.28M | -7.63M | 160.75K |
| 2022 | -59.53M | -7.51M | 1K |
| 2023 | -48.44M | -1.1M | 9K |
ACHL Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 173.37M | 266.35M | 177.84M | 97.59M | 10.68M |
Operating activities | |||||
Net income | -69.93M | -71.17M | -61.09M | -33.19M | -13.99M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 4.71M | 3.69M | 3.28M | 772K | 302K |
Stock-based compensation expense | 6.35M | 7.02M | 6.31M | 2.99M | 719K |
| Deferred income tax benefit | 6.35M | 7.02M | 6.31M | 2.99M | 719K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 1.90M | -2.57M | 5.25M | 548K |
Cash generated by operating activities | -48.44M | -59.53M | -59.28M | -25.25M | -14.14M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.1M | -7.51M | -7.63M | -11.84M | -942K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.1M | -7.51M | -7.63M | -11.84M | -942K |
Financing activities | |||||
Common Stock Issued | 9K | 1K | 160.73M | 114.58M | 94.00M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 9K | 1K | 160.75K | 113.70M | 93.62M |
Net Change In Cash | -41.79M | -92.98M | 88.50M | 80.25M | 86.91M |
Cash at end of period | 131.57M | 173.37M | 266.35M | 177.84M | 97.59M |
| Data source | Data source | Data source |